Optimizing CML Management: Shared Decision Making and Enhancing the Patient Experience - Episode 1

Understanding CML: Your Journey from Diagnosis to Treatment

July 31, 2024
Jorge E. Cortes, MD

,
Joannie Clements

,
Claire Saxton

A panel of experts on introduce a discussion on chronic myeloid leukemia (CML) with an overview of the disease, focusing on its subtypes and characteristics.

Now Viewing
EP. 1: Understanding CML: Your Journey from Diagnosis to Treatment
EP. 2: Navigating CML: Tools to Empower Patients and Caregivers
EP. 3: Empowering CML Caregivers: Strategies and Support Systems
EP. 4: Starting CML Treatment: Collaborative Choices for Better Outcomes
EP. 5: Open Dialogue in CML Care: Setting Expectations, Managing Side Effects, and Optimizing Patient Quality of Life
EP. 6: When CML Therapy Shifts: Collaborative Approaches to Treatment Changes
EP. 7: CML Treatment: Scenarios that Necessitate Switching Therapy
EP. 8: Ensuring Informed CML Care from Diagnosis Onward
EP. 9: Advancing CML Management Towards an Ideal Patient Journey

This program was made possible with support from Novartis Pharmaceuticals.

Video content above is prompted by the following questions:

  • Please provide some background on CML. What are the different subtypes of CML and how do they differ in terms of presentation and management?
  • Can you explain the typical prognosis and disease course for someone diagnosed with CML? How do you educate newly diagnosed patients on what to expect?

Related Content:

Optimizing CML Management: Shared Decision Making and Enhancing the Patient ExperienceGeorgia Cancer Center at Augusta UniversityBlood CancersCURE Expert Connections
Identifying Cardiovascular Disease Risk in Cancer Survivors
Education on MPN Symptoms, Treatments Leads to Greater Involvement in Care
Reblozyl May Be ‘The Standard of Care’ Now in Lower-Risk MDS, Anemia